Website Phytovo is a Colorado based life science company, harnessing the untapped potential of producing complex therapeutics in plants. Phytovo’s protein expression platform offers rapid developmental timelines and lower capital expenditures compared to legacy systems, enabling faster drug discovery at a reduced cost.
Website PearlSci is a dedicated oncology company that is working to better the lives of cancer patients through development of novel therapeutics.
Kelly Neuroscience offers consulting to pharmaceutical companies and nonprofit foundations on traumatic brain injury concerns.
Website Cytegen is developing therapeutics to improve mitochondrial function and impact multiple neurological and metabolic diseases.
Website RheumaGen is a private biotechnology company engineering a new class of therapeutic to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado.
Website HepQuant develops non-invasive, quantitative tests that measure liver health. The HepQuant DuO Test is a Laboratory Developed Test (LDT) that enables healthcare providers to manage patients with liver diseases more effectively. It delivers information about liver cell function and portal-systemic shunting, attributes of liver disease that are associated with clinical outcomes. Results may be…
Website Vona Oncology is an early clinical stage bio-pharmaceutical company developing targeted therapeutics to treat aggressive cancers such as triple-negative breast cancer (TNBC), ovarian cancer, and melanoma. TNBC is the initial indication for Vona’s small molecule drug, VDX-111.
Website PharmaLogic is a North American radiopharmaceutical and Mobile PET/CT operations company, dedicated to nuclear medicine and the science of radiopharmaceutical production. Their commitment to these fields extends to the communities they serve. They further differentiate by offering a unique suite of solutions addressing the dynamic challenges facing the nuclear imaging market. PharmaLogic utilizes a…
Website At Pathways Bioscience, we believe that the best way to improve health span and overcome health and wellness problems associated with aging is to support the body’s own defense mechanisms that allow it to protect and heal itself. We are focused on the discovery and development of new agents that regulate gene expression and…
Website Op-T is a clinical-stage company that has developed a new therapeutic for controlling inflammation in autoimmune diseases, acute inflammatory conditions, and certain chronic conditions across multiple species. The company has received IND approvals from the FDA for Phase 1 studies in humans with type 1 diabetes (T1D) and in healthy humans toward later studies…